Injection site swelling and redness; Injection site swelling and redness; Low grade fever; Nausea; This is a spontaneous report from a contactable nurse reporting for herself. A 54-year-old female patient received bnt162b2 (BNT162B2) (Lot# EJ1686, Exp date 31Mar2021), via an unspecified route of administration, on 05Jan2021, at single dose, for COVID-19 immunisation. Medical history and concomitant medications were none. The patient experienced injection site swelling and redness, low grade fever and nausea all on 06Jan2021 with outcome of unknown. Therapeutic measures were taken as result of the events and included treatment with a 1000 mg Tylenol. The events were considered related (source of assessment: primary source reporter, method of assessment: global introspection).